Human Molecular Genetics, 2000, Vol. 9, No. 3 447-452
© 2000 Oxford University Press
Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease
The Cyprus Institute of Neurology and Genetics, Department of Molecular Genetics, PO Box 3462, 6 International Airport Avenue, Ayios Dhometios, 1683 Nicosia, Cyprus and 1Department of Nephrology, Nicosia General Hospital, Nicosia, Cyprus
Polycystic kidney disease (ADPKD) is a condition with an autosomal dominant mode of inheritance and adult onset. Two forms of the disease, ADPKD1 and ADPKD2, caused by mutations in PKD1 and PKD2, respectively, are very similar, except that ADPKD1 patients run a more severe course. At the cellular level, ADPKD1 was first shown to be recessive, since somatic second hits are perhaps necessary for cyst formation. The near identical phenotype had suggested that ADPKD1 and ADPKD2 might have a similar pathogenesis and that the two gene products, poly- cystins 1 and 2, are part of a common developmental pathway. Work in transgenic mice showed that somatic loss of Pkd2 expression is necessary for renal cyst formation, and recently we showed that somatic mutations inactivating the inherited healthy allele were present in 9 of 23 cysts from a human ADPKD2 kidney, supporting a two-hit loss-of-function model for ADPKD2 cystogenesis. Here, we provide the first direct genetic evidence that polycystins 1 and 2 do interact, perhaps as part of a larger complex. In cystic DNA from a kidney of an ADPKD1 patient, we showed somatic mutations not only in the PKD1 gene of certain cysts, but also in the PKD2 gene of others, generating a trans-heterozygous state with mutations in both genes. One mutation in PKD1 is of germinal nature and the mutation in the PKD2 gene is of somatic nature. The implications of such a situation are enormous, not only for ADPKD, but also for many other conditions with phenotypic heterogeneity and age-dependent penetrance.
+ To whom correspondence should be addressed. Tel: +357 2 392655; Fax: +357 2 358237; email: deltasco@mdrtc.cing.ac.cy
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Lesma, S. M. Sirchia, S. Ancona, S. Carelli, S. Bosari, F. Ghelma, E. Montanari, A. M. Di Giulio, and A. Gorio The Methylation of the TSC2 Promoter Underlies the Abnormal Growth of TSC2 Angiomyolipoma-Derived Smooth Muscle Cells Am. J. Pathol., June 1, 2009; 174(6): 2150 - 2159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Akers, E. Johnson, G. K. Steinberg, J. M. Zabramski, and D. A. Marchuk Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis Hum. Mol. Genet., March 1, 2009; 18(5): 919 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Peces, C. Peces, E. Coto, and R. Selgas Bilineal inheritance of type 1 autosomal dominant polycystic kidney disease (ADPKD) and recurrent fetal loss NDT Plus, October 1, 2008; 1(5): 289 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Sehgal and S. Mukhopadhyay Dysfunctional Intracellular Trafficking in the Pathobiology of Pulmonary Arterial Hypertension Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 31 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Sehgal and S. Mukhopadhyay Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs? Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H77 - H85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Gallagher, S. Hoffmann, N. Brown, A. Cedzich, S. Meruvu, D. Podlich, Y. Feng, V. Konecke, U. de Vries, H.-P. Hammes, et al. A Truncated Polycystin-2 Protein Causes Polycystic Kidney Disease and Retinal Degeneration in Transgenic Rats J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2719 - 2730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-T. Jiang, Y.-Y. Chiou, E. Wang, H.-K. Lin, Y.-T. Lin, Y.-C. Chi, C.-K. L. Wang, M.-J. Tang, and H. Li Defining a Link with Autosomal-Dominant Polycystic Kidney Disease in Mice with Congenitally Low Expression of Pkd1 Am. J. Pathol., January 1, 2006; 168(1): 205 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. S. L.-v. Leeuwen, J. G. Dauwerse, H. J. Baelde, W. N. Leonhard, A. van de Wal, C. J. Ward, S. Verbeek, M. C. DeRuiter, M. H. Breuning, E. de Heer, et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease Hum. Mol. Genet., December 15, 2004; 13(24): 3069 - 3077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Igarashi and S. Somlo Genetics and Pathogenesis of Polycystic Kidney Disease J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2384 - 2398. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rodova, M. R. Islam, R. L. Maser, and J. P. Calvet The Polycystic Kidney Disease-1 Promoter Is a Target of the beta -Catenin/T-cell Factor Pathway J. Biol. Chem., August 9, 2002; 277(33): 29577 - 29583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wu, X. Tian, S. Nishimura, G. S. Markowitz, V. D'Agati, J. Hoon Park, L. Yao, L. Li, L. Geng, H. Zhao, et al. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease Hum. Mol. Genet., August 1, 2002; 11(16): 1845 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Pritchard, J. A. Sloane-Stanley, J. A. Sharpe, R. Aspinwall, W. Lu, V. Buckle, L. Strmecki, D. Walker, C. J. Ward, C. E. Alpers, et al. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype Hum. Mol. Genet., November 1, 2000; 9(18): 2617 - 2627. [Abstract] [Full Text] [PDF]
|
|